Onsdag 5 Februari | 07:43:44 Europe / Stockholm

Kalender

Tid*
2025-08-06 08:30 Kvartalsrapport 2025-Q2
2025-06-04 N/A Årsstämma
2025-02-12 08:30 Bokslutskommuniké 2024
2024-08-07 - Kvartalsrapport 2024-Q2
2024-06-06 - X-dag ordinarie utdelning BIOBV 0.00 EUR
2024-06-05 - Årsstämma
2024-02-14 - Bokslutskommuniké 2023
2023-08-09 - Kvartalsrapport 2023-Q2
2023-06-15 - X-dag ordinarie utdelning BIOBV 0.00 EUR
2023-06-14 - Årsstämma
2023-03-22 - Bokslutskommuniké 2022
2022-08-10 - Kvartalsrapport 2022-Q2
2022-06-16 - X-dag ordinarie utdelning BIOBV 0.00 EUR
2022-06-15 - Årsstämma
2022-03-09 - Extra Bolagsstämma 2022
2022-02-16 - Bokslutskommuniké 2021
2021-08-11 - Kvartalsrapport 2021-Q2
2021-04-22 - X-dag ordinarie utdelning BIOBV 0.00 EUR
2021-04-21 - Årsstämma
2021-02-17 - Bokslutskommuniké 2020
2020-08-12 - Kvartalsrapport 2020-Q2
2020-04-23 - X-dag ordinarie utdelning BIOBV 0.00 EUR
2020-04-22 - Årsstämma
2020-02-19 - Bokslutskommuniké 2019
2019-08-14 - Kvartalsrapport 2019-Q2
2019-04-25 - X-dag ordinarie utdelning BIOBV 0.00 EUR
2019-04-24 - Årsstämma
2019-02-20 - Bokslutskommuniké 2018
2018-08-22 - Kvartalsrapport 2018-Q2
2018-08-16 - Extra Bolagsstämma 2018
2018-04-26 - X-dag ordinarie utdelning BIOBV 0.00 EUR
2018-04-25 - Årsstämma
2018-02-28 - Bokslutskommuniké 2017
2017-07-27 - Kvartalsrapport 2017-Q2
2017-04-27 - X-dag ordinarie utdelning BIOBV 0.00 EUR
2017-04-26 - Årsstämma
2017-02-02 - Bokslutskommuniké 2016
2016-10-20 - 15-10 2016-Q3
2016-08-10 - Kvartalsrapport 2016-Q2
2016-05-12 - Kvartalsrapport 2016-Q1
2016-04-26 - X-dag ordinarie utdelning BIOBV 0.00 EUR
2016-04-25 - Årsstämma
2016-02-25 - Bokslutskommuniké 2015
2015-10-22 - Kvartalsrapport 2015-Q3
2015-08-20 - Kvartalsrapport 2015-Q2
2015-05-07 - Kvartalsrapport 2015-Q1
2015-04-21 - X-dag ordinarie utdelning BIOBV 0.00 EUR
2015-04-20 - Årsstämma
2015-02-26 - Bokslutskommuniké 2014
2014-10-23 - Kvartalsrapport 2014-Q3
2014-08-21 - Kvartalsrapport 2014-Q2
2014-05-08 - Kvartalsrapport 2014-Q1
2014-04-15 - X-dag ordinarie utdelning BIOBV 0.72 EUR
2014-04-14 - Årsstämma
2014-02-27 - Bokslutskommuniké 2013
2013-10-24 - Kvartalsrapport 2013-Q3
2013-08-08 - Kvartalsrapport 2013-Q2
2013-04-25 - Kvartalsrapport 2013-Q1
2013-04-09 - X-dag ordinarie utdelning BIOBV 0.50 EUR
2013-04-08 - Årsstämma
2013-02-27 - Bokslutskommuniké 2012
2012-10-25 - Kvartalsrapport 2012-Q3
2012-08-16 - Kvartalsrapport 2012-Q2
2012-04-26 - Kvartalsrapport 2012-Q1
2012-04-12 - X-dag ordinarie utdelning BIOBV 1.00 EUR
2012-04-11 - Årsstämma
2012-02-29 - Bokslutskommuniké 2011
2011-11-23 - Extra Bolagsstämma 2011
2011-10-20 - Kvartalsrapport 2011-Q3
2011-08-18 - Kvartalsrapport 2011-Q2
2011-04-28 - Kvartalsrapport 2011-Q1
2011-04-14 - X-dag ordinarie utdelning BIOBV 0.00 EUR
2011-04-13 - Årsstämma
2011-03-01 - Bokslutskommuniké 2010
2010-04-26 - X-dag ordinarie utdelning BIOBV 0.00 EUR
2009-04-21 - X-dag ordinarie utdelning BIOBV 0.00 EUR
2008-04-22 - X-dag ordinarie utdelning BIOBV 0.00 EUR
2007-04-20 - X-dag ordinarie utdelning BIOBV 0.00 EUR
2006-04-21 - X-dag ordinarie utdelning BIOBV 0.00 EUR
2005-04-22 - X-dag ordinarie utdelning BIOBV 0.00 EUR
2004-04-16 - X-dag ordinarie utdelning BIOBV 0.00 EUR
2003-04-10 - X-dag ordinarie utdelning BIOBV 0.00 EUR
2002-04-02 - X-dag ordinarie utdelning BIOBV 0.00 EUR
2001-03-28 - X-dag ordinarie utdelning BIOBV 0.00 EUR
2000-04-07 - X-dag ordinarie utdelning BIOBV 0.00 EUR
1999-04-22 - X-dag ordinarie utdelning BIOBV 0.00 EUR

Beskrivning

LandFinland
ListaSmall Cap Helsinki
SektorHälsovård
IndustriMedicinteknik
Biohit är verksamt inom medicinteknik. Bolaget utvecklar och tillverkar laboratorieutrustning, förnödenheter samt diagnostiska analyssystem anpassade för forskning, vård och industrilaboratorium. Utöver huvudverksamheten erbjuds teknisk support, underhåll samt utbildningstjänster inom nämnt arbetsområde. Störst verksamhet återfinns inom den nordiska marknaden. Bolaget har sitt huvudkontor i Helsingfors.
2025-01-31 10:30:00

BIOHIT introduces the FAEX Sample System for stool sample collection and handling

Biohit Oyj Press release 31 January 2025 at 11.30 am local time (EEST)

BIOHIT Oyj is excited to announce the launch of the BIOHIT FAEX Sample System, a revolutionary stool sample collection and handling solution that can be seamlessly incorporated into any diagnostic workflow. Designed for precision, efficiency and flexibility, this innovative, practical and reliable system addresses the needs of both patients and laboratories.

The BIOHIT FAEX Sample System combines multi-functionality with ease of use. It serves as both a standard test tube and a convenient dropper tube, enabling precise and reproducible sample dispensing for ELISAs, chemiluminescence assays, lateral flow tests and proprietary diagnostic kits. The precision-engineered collection stick ensures consistent and accurate sample collection, while a screw-tight cap with leak-proof threads promotes safe and hygienic handling, transport, storage and disposal.

CE-marked and compliant with Regulation (EU) 2017/746 for In Vitro Diagnostic Devices (IVDR), the BIOHIT FAEX Sample System meets the highest regulatory standards. Whether used as a standalone component or as part of a diagnostic kit, it is a versatile and efficient solution that simplifies stool sample collection and processing in any setting.

Jussi Hahtela, CEO of BIOHIT OYJ, commented: The BIOHIT FAEX Sample System exemplifies our commitment to providing innovative solutions that address real-world challenges for patients and laboratories. By combining precision and efficiency, we are empowering customers to streamline their workflows and improve the patient experience. The unique adaptability of the BIOHIT FAEX Sample System makes it an excellent addition to our own and other manufacturers’ diagnostic kits, while also serving as a reliable standalone solution for laboratories.”

Visit https://www.biohithealthcare.com/en/products/biohit-faex-sample-system/ to find out more about the BIOHIT FAEX Sample System.

Jussi Hahtela, CEO, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohit.fi

Biohit in brief

Biohit Oyj is a Finnish biotechnology company that operates internationally. Biohit’s mission is Innovating for Health – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki and has subsidiaries in Italy and the United Kingdom. Biohit’s series B share (BIOBV) is listed on Nasdaq OMX Helsinki in the Small Cap/Healthcare group.

www.biohithealthcare.com